SG Americas Securities, LLC VNDA VANDA PHARMACEUTICALS COM

Ownership history in SG Americas Securities, LLC  ·  38 quarters on record

AI Ownership Summary

SG Americas Securities, LLC reported VANDA PHARMACEUTICALS COM (VNDA) in 38 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows VNDA at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this VNDA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SG Americas Securities, LLC's position in VANDA PHARMACEUTICALS COM, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

VNDA was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How SG Americas Securities, LLC held VNDA — position size vs. price
% of Fund (quarterly)    VNDA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 21,042 +10,235 +94.7% 0.00% $145 2026-04-16 $7.16
2025 Q4 REDUCED 46.7% -21.7% 10,807 -9,483 -46.7% 0.00% $95K 2026-01-09 $7.33
2025 Q1 REDUCED 21.5% +2.8% 20,290 -5,571 -21.5% 0.00% $93K 2025-04-15 $4.37
2024 Q4 ADDED 25,861 +5,459 +26.8% 0.00% $124K 2025-01-17 $4.36
2024 Q3 ADDED 20,402 +9,580 +88.5% 0.00% $96K 2024-10-03 $4.50
2024 Q2 REDUCED 51.4% -17.0% 10,822 -11,426 -51.4% 0.00% $61K 2024-07-12 $5.92
2023 Q4 ADDED 22,248 +2,488 +12.6% 0.00% $94K 2024-01-12 $3.85
31 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About SG Americas Securities, LLC and VNDA

These are the practical questions this page is built to answer before you even open the full history table.

How long has SG Americas Securities, LLC reported owning VNDA?

SG Americas Securities, LLC reported VNDA across 7 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported VNDA position in SG Americas Securities, LLC's portfolio?

The largest reported portfolio weight for VNDA was 0.00% in 2023 Q4.

What is the latest reported VNDA position on this page?

The most recent filing on this page is 2026 Q1, when SG Americas Securities, LLC reported 21,042 shares, equal to 0.00% of portfolio, with an estimated market value of $145.

What does the chart on this VNDA ownership page compare?

The chart compares SG Americas Securities, LLC's quarterly VNDA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SG Americas Securities, LLC time their VNDA position?

Based on 13F filing dates vs. subsequent VNDA price moves, SG Americas Securities, LLC correctly timed 21 out of 37 reported position changes (57%). The annualised alpha on VNDA relative to SPY over the holding period was +100.1%.

← Back to SG Americas Securities, LLC Holdings